Collegium to Report First Quarter 2025 Financial Results on May 8, 2025
Collegium Pharmaceutical (Nasdaq: COLL) has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET on the same day to discuss the results.
Investors can access the conference call by dialing (877) 407-8037 for U.S. participants or (201) 689-8037 for international callers. An audio webcast will be available through the Investors section of Collegium's website and will remain accessible for replay approximately two hours after the event.
Collegium Pharmaceutical (Nasdaq: COLL) ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 8 maggio 2025, dopo la chiusura dei mercati. La società terrà una conference call e una trasmissione in webcast alle 16:30 ET dello stesso giorno per discutere i risultati.
Gli investitori potranno partecipare alla conference call chiamando il numero (877) 407-8037 per gli Stati Uniti o il (201) 689-8037 per chiamate internazionali. Un webcast audio sarà disponibile nella sezione Investitori del sito web di Collegium e resterà accessibile per la replica per circa due ore dopo l'evento.
Collegium Pharmaceutical (Nasdaq: COLL) ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el jueves 8 de mayo de 2025, después del cierre del mercado. La compañía realizará una llamada conferencia y una transmisión por webcast a las 4:30 p.m. ET del mismo día para analizar los resultados.
Los inversores pueden acceder a la llamada conferencia marcando (877) 407-8037 para participantes en EE.UU. o (201) 689-8037 para llamadas internacionales. Un webcast de audio estará disponible en la sección de Inversores del sitio web de Collegium y permanecerá accesible para reproducción aproximadamente dos horas después del evento.
Collegium Pharmaceutical (나스닥: COLL)은 2025년 5월 8일 목요일, 장 마감 후에 2025년 1분기 재무 실적 발표를 예정하고 있습니다. 회사는 같은 날 오후 4시 30분(동부시간)에 실적을 논의하기 위한 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
투자자들은 미국 내 참여자는 (877) 407-8037, 해외 참여자는 (201) 689-8037로 전화하여 컨퍼런스 콜에 접속할 수 있습니다. 오디오 웹캐스트는 Collegium 웹사이트의 투자자 섹션을 통해 제공되며, 행사 종료 후 약 두 시간 동안 다시 듣기가 가능합니다.
Collegium Pharmaceutical (Nasdaq : COLL) a prévu d’annoncer ses résultats financiers du premier trimestre 2025 le jeudi 8 mai 2025, après la clôture des marchés. La société organisera une conférence téléphonique et une webdiffusion à 16h30 ET le même jour pour discuter des résultats.
Les investisseurs peuvent accéder à la conférence téléphonique en composant le (877) 407-8037 pour les participants américains ou le (201) 689-8037 pour les appels internationaux. Une webdiffusion audio sera disponible dans la section Investisseurs du site web de Collegium et restera accessible en replay environ deux heures après l’événement.
Collegium Pharmaceutical (Nasdaq: COLL) hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 8. Mai 2025, nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und einen Webcast veranstalten, um die Ergebnisse zu besprechen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie für Teilnehmer aus den USA die Nummer (877) 407-8037 oder für internationale Anrufer die Nummer (201) 689-8037 wählen. Ein Audio-Webcast wird im Investor-Bereich der Collegium-Website verfügbar sein und etwa zwei Stunden nach der Veranstaltung zur Wiedergabe bereitstehen.
- None.
- None.
STOUGHTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report first quarter 2025 financial results after the market closes on Thursday, May 8, 2025. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2025 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and recently acquired Jornay PM, a treatment for ADHD, establishing a presence in neuropsychiatry. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com
FAQ
When will Collegium Pharmaceutical (COLL) release Q1 2025 earnings?
How can investors join Collegium's Q1 2025 earnings call?
What time is Collegium's Q1 2025 earnings conference call?
Where can I find the replay of Collegium's Q1 2025 earnings webcast?
